Well, nothing strange:
Launch of New Targeted Therapeutics will
Drive Market Growth during the Forecast Period 2010 - 2017
The drug discovery and development process in the oncology sector is driven by the unmet needs of patients. The unmet need for most of the cancers is the availability of safe and effective targeted drugs to treat the late stages of the disease, when patients often stop responding to chemotherapy. The presence of many targeted therapeutics that treat late-stage cancers in Phase III product pipelines supports this point.
Product pipelines for all the therapeutic indications have targeted therapeutics in Phase III. The launch of some of the targeted therapeutics is expected to drive growth in the oncology therapeutics market during the forecast period 2010 - 2017.
No comments:
Post a Comment